During the past decade, Segeberger Kliniken GmbH conducted 23 clinical trials. In the 10-year time frame, 23 clinical trials started and 3 clinical trials were completed, i.e. on average, 13% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 2 clinical trials were completed. i.e. 22.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Segeberger Kliniken GmbH" #1 sponsor was "Abbott Medical Devices" with 8 trials, followed by "Biotronik AG" with 8 trials sponsored, "Deutsches Herzzentrum Muenchen" with 6 trials sponsored, "Biosensors Europe SA" with 2 trials sponsored and "IHF GmbH - Institut für Herzinfarktforschung" with 2 trials sponsored. Other sponsors include 12 different institutions and companies that sponsored additional 21 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Segeberger Kliniken GmbH" #1 collaborator was "A.O. Ospedale Papa Giovanni XXIII" with 1 trials as a collaborator, "Abbott Medical Devices" with 1 trials as a collaborator, "Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)" with 1 trials as a collaborator, "Accelopment AG" with 1 trials as a collaborator and "Bayer" with 1 trials as a collaborator. Other collaborators include 23 different institutions and companies that were collaborators in the rest 33 trials.

According to Clinical.Site data, the most researched conditions in "Segeberger Kliniken GmbH" are "Coronary Artery Disease" (15 trials), "Coronary Artery Stenosis" (5 trials), "Atrial Fibrillation" (4 trials), "Coronary Disease" (4 trials) and "Heart Failure" (3 trials). Many other conditions were trialed in "Segeberger Kliniken GmbH" in a lesser frequency.

Most popular intervention types in "Segeberger Kliniken GmbH" are "Device" (33 trials), "Drug" (6 trials), "Other" (2 trials), "Procedure" (2 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Percutaneous Coronary Intervention" (2 trials), "Percutaneous coronary intervention" (2 trials), "XIENCE V®/ XIENCE PRIME™" (2 trials), "ABSORB Scaffold" (1 trials) and "ABSORB scaffold" (1 trials). Other intervention names were less common.

The vast majority of trials in "Segeberger Kliniken GmbH" are 41 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Segeberger Kliniken GmbH". undefined are not yet recruiting, 7 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 24 completed trials in Segeberger Kliniken GmbH, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Segeberger Kliniken GmbH, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 9 trials, and there were also 22 trials that are defined as “Not Applicable".

Segeberger Kliniken GmbH has several departments that took part in Clinical trials: "Herz-Kreislauf-Zentrum Segeberger Kliniken GmbH" - 7 trials, "Herzzentrum, Segeberger Kliniken GmbH" - 5 trials